Transdiagnostic Dysfunctions in Brain Modules Across Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Connectome-Based Study.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
10 04 2020
Historique:
pubmed: 23 11 2019
medline: 15 5 2021
entrez: 23 11 2019
Statut: ppublish

Résumé

Psychiatric disorders, including schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD), share clinical and neurobiological features. Because previous investigations of functional dysconnectivity have mainly focused on single disorders, the transdiagnostic alterations in the functional connectome architecture of the brain remain poorly understood. We collected resting-state functional magnetic resonance imaging data from 512 participants, including 121 with SCZ, 100 with BD, 108 with MDD, and 183 healthy controls. Individual functional brain connectomes were constructed in a voxelwise manner, and the modular architectures were examined at different scales, including (1) global modularity, (2) module-specific segregation and intra- and intermodular connections, and (3) nodal participation coefficients. The correlation of these modular measures with clinical scores was also examined. We reliably identify common alterations in modular organization in patients compared to controls, including (1) lower global modularity; (2) lower modular segregation in the frontoparietal, subcortical, visual, and sensorimotor modules driven by more intermodular connections; and (3) higher participation coefficients in several network connectors (the dorsolateral prefrontal cortex and angular gyrus) and the thalamus. Furthermore, the alterations in the SCZ group are more widespread than those of the BD and MDD groups and involve more intermodular connections, lower modular segregation and higher connector integrity. These alterations in modular organization significantly correlate with clinical scores in patients. This study demonstrates common hyper-integrated modular architectures of functional brain networks among patients with SCZ, BD, and MDD. These findings reveal a transdiagnostic mechanism of network dysfunction across psychiatric disorders from a connectomic perspective.

Identifiants

pubmed: 31755957
pii: 5637928
doi: 10.1093/schbul/sbz111
pmc: PMC7147584
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-712

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Am J Psychiatry. 2006 Oct;163(10):1747-53
pubmed: 17012685
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Neurosci Bull. 2015 Apr;31(2):207-19
pubmed: 25761914
Neuron. 2012 Oct 4;76(1):223-39
pubmed: 23040817
Neuroimage. 2017 May 1;151:55-64
pubmed: 27894892
Brain. 2016 Jan;139(Pt 1):276-91
pubmed: 26493637
Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2066-75
pubmed: 24778245
Am J Psychiatry. 2010 Jan;167(1):78-85
pubmed: 19952077
Biol Psychiatry. 2019 Mar 1;85(5):379-388
pubmed: 30612699
Hum Brain Mapp. 2015 Feb;36(2):768-78
pubmed: 25332057
Neurosci Biobehav Rev. 2016 Dec;71:313-322
pubmed: 27590830
Nature. 2005 Feb 24;433(7028):895-900
pubmed: 15729348
Am J Psychiatry. 2012 Jul;169(7):719-24
pubmed: 22581236
Hum Brain Mapp. 2015 Aug;36(8):2915-27
pubmed: 25930660
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
Biol Psychiatry. 2015 Feb 1;77(3):223-235
pubmed: 25444171
Neuroimage. 2017 Oct 15;160:152-167
pubmed: 28232122
Cereb Cortex. 2018 Apr 1;28(4):1383-1395
pubmed: 29300840
Nat Rev Neurosci. 2006 Oct;7(10):818-27
pubmed: 16988657
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11020-5
pubmed: 20534464
Prog Neurobiol. 2014 May;116:58-65
pubmed: 24525149
Schizophr Bull. 2019 Mar 7;45(2):450-463
pubmed: 29897593
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Psychol Med. 2015 Mar;45(4):759-70
pubmed: 25089761
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Schizophr Bull. 2019 Oct 24;45(6):1242-1250
pubmed: 30561724
Am J Psychiatry. 2017 Oct 1;174(10):971-979
pubmed: 28618857
Trends Cogn Sci. 2019 Jan;23(1):34-50
pubmed: 30455082
Am J Psychiatry. 2017 Jul 1;174(7):657-666
pubmed: 28135847
Ann Neurol. 1990 Nov;28(5):597-613
pubmed: 2260847
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Schizophr Bull. 2011 Sep;37(5):1009-16
pubmed: 20164122
J Neurophysiol. 1996 Sep;76(3):1367-95
pubmed: 8890259
Schizophr Bull. 2014 Nov;40(6):1227-43
pubmed: 25031221
Biol Psychiatry. 2015 Jun 1;77(11):989-96
pubmed: 25524754
Psychiatry Res. 2009 Aug 30;173(2):150-4
pubmed: 19545981
Schizophr Bull. 2018 Feb 15;44(2):419-431
pubmed: 28605528
Nat Commun. 2018 Aug 2;9(1):3028
pubmed: 30072715
Nat Rev Neurosci. 2015 Mar;16(3):159-72
pubmed: 25697159
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6798-807
pubmed: 26598686
Schizophr Bull. 2017 Jul 1;43(4):914-924
pubmed: 27872268
Schizophr Bull. 1994;20(3):441-51
pubmed: 7526446
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
J Psychiatry Neurosci. 2018 Mar;43(2):131-142
pubmed: 29481320
Soc Cogn Affect Neurosci. 2017 Jul 1;12(7):1047-1062
pubmed: 28402561
Schizophr Bull. 2019 Sep 11;45(5):1143-1151
pubmed: 30500946
Schizophr Bull. 2017 Sep 1;43(5):982-992
pubmed: 28911049
Neuropsychopharmacology. 2017 Mar;42(4):933-940
pubmed: 27782128
Hum Brain Mapp. 2012 Nov;33(11):2535-49
pubmed: 21922601
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Annu Rev Psychol. 2016;67:613-40
pubmed: 26393868
Front Integr Neurosci. 2014 Aug 19;8:65
pubmed: 25191234
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82
pubmed: 11209064
Transl Psychiatry. 2012 Mar 13;2:e90
pubmed: 22832855
JAMA. 2003 Jun 18;289(23):3125-34
pubmed: 12813118
Biol Psychiatry. 2001 Dec 1;50(11):825-44
pubmed: 11743939
Nat Neurosci. 2011 May 29;14(7):830-2
pubmed: 21623362
Schizophr Bull. 2019 Apr 25;45(3):689-697
pubmed: 29850901
Neuron. 2013 Aug 21;79(4):798-813
pubmed: 23972601
Magn Reson Med. 1995 Oct;34(4):537-41
pubmed: 8524021
J Am Acad Child Adolesc Psychiatry. 1995 Oct;34(10):1273-83
pubmed: 7592264
Neuroimage. 2012 Oct 1;62(4):2296-314
pubmed: 22387165
Schizophr Bull. 2011 Mar;37(2):389-93
pubmed: 19687152
Cereb Cortex. 2018 Dec 1;28(12):4179-4194
pubmed: 29136110
Front Syst Neurosci. 2010 May 14;4:13
pubmed: 20577591
Psychiatry Res. 2013 Dec 15;210(2):479-84
pubmed: 23916624
JAMA Psychiatry. 2016 Mar;73(3):191-2
pubmed: 26765254
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11583-8
pubmed: 23798414
Lancet. 2018 Apr 28;391(10131):1683-1692
pubmed: 29726344
Am J Psychiatry. 2009 Sep;166(9):1041-7
pubmed: 19605535
PLoS One. 2009;4(4):e5226
pubmed: 19381298
Biol Psychiatry. 2019 Apr 1;85(7):573-583
pubmed: 30691673
Schizophr Bull. 2016 Nov;42(6):1446-1456
pubmed: 27352783
J Psychosom Res. 2002 Aug;53(2):647-54
pubmed: 12169339
Biol Psychiatry. 2018 Sep 15;84(6):452-459
pubmed: 29779670
Neurosci Biobehav Rev. 2018 Jan;84:272-288
pubmed: 28859997
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Neuroscientist. 2014 Dec;20(6):652-64
pubmed: 24622818
Neuron. 2012 Jun 21;74(6):990-1004
pubmed: 22726830
Genet Soc Gen Psychol Monogr. 2004 Aug;130(3):241-70
pubmed: 15819307
Neuropsychopharmacology. 2019 Apr;44(5):869-875
pubmed: 30127342
Brain. 2012 May;135(Pt 5):1498-507
pubmed: 22418737
J Affect Disord. 2017 Aug 1;217:125-131
pubmed: 28407555
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E4997-5006
pubmed: 25368199
J Affect Disord. 2016 Jun;197:116-24
pubmed: 26991366
Schizophr Bull. 2018 Feb 15;44(2):409-418
pubmed: 28520931
Trends Cogn Sci. 2013 Dec;17(12):641-7
pubmed: 24238779
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
J Affect Disord. 2018 Aug 15;236:266-273
pubmed: 29751242

Auteurs

Qing Ma (Q)

National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Beijing Key Laboratory of Brain Imaging and Connectomics, Beijing Normal University, Beijing, China.
IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.

Yanqing Tang (Y)

Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
Brain Function Research Section, The First Affiliated Hospital of China Medical University, Shenyang, China.

Fei Wang (F)

Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
Brain Function Research Section, The First Affiliated Hospital of China Medical University, Shenyang, China.

Xuhong Liao (X)

National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Beijing Key Laboratory of Brain Imaging and Connectomics, Beijing Normal University, Beijing, China.
IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.

Xiaowei Jiang (X)

Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.

Shengnan Wei (S)

Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.

Andrea Mechelli (A)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Yong He (Y)

National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Beijing Key Laboratory of Brain Imaging and Connectomics, Beijing Normal University, Beijing, China.
IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.

Mingrui Xia (M)

National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Beijing Key Laboratory of Brain Imaging and Connectomics, Beijing Normal University, Beijing, China.
IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH